Quality of life in asthmatic outpatients.

J Asthma

Family Health Unit, Matosinhos Health Centre, Matosinhos, Portugal.

Published: March 2008

Asthma patients incur a great cost in terms of loss of quality of life. The purpose of this study is to evaluate the relative contribution and relationship of several patient- and disease-related factors, measured by several variables, to the quality of life in adults with asthma. Two hundred and ten asthmatic outpatients over 18 years old, registered in a Family Health Unit, were randomly selected to complete the Asthma Quality of Life (AQLQ) and Short Form Generic questionnaires (SF-36), respectively. Single and multiple linear regression models were developed to explain the variability of the summary scores of AQLQ and Physical and Mental Health SF-36. As potential predictors, the following independent variables were used: gender, age, number of comorbidities, asthma severity following the Global Initiative for Asthma (GINA) criteria, asthma control (measured by ACQ questionnaire), %FEV1 (forced expiratory volume in the first second) and, for the first time, Graffar Score to assess socioeconomical features. The Graffar Score is an index that divides the population in 5 socioeconomic layers. We report the best Adjusted R Square of these models published in the literature, ranging from 0.40 to 0.76. Women showed poorer quality of life than men. The best predictor of AQLQ was ACQ, followed by Asthma Severity, Gender and %FEV1. The best predictors of Physical and Mental Health SF-36 were, by decreasing importance, ACQ, number of comorbidities, Gender and Graffar Score. We note that the variable number of comorbidities was included in both SF-36 models, but not in AQLQ model. Asthma Severity and %FEV1 did not enter into SF-36 models. We conclude that besides clinical and functional measures, the evaluation process of the overall health status must incorporate quality-of-life measures.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02770900701815495DOI Listing

Publication Analysis

Top Keywords

quality life
20
number comorbidities
12
asthma severity
12
graffar score
12
asthmatic outpatients
8
asthma
8
physical mental
8
mental health
8
health sf-36
8
sf-36 models
8

Similar Publications

Background: To investigate the effect of Midnight-noon Ebb-flow combined with five-element music therapy in the continuous nursing of patients with chronic wounds.

Methods: From March 2022 to November 2023, we recruited 50 eligible chronic wound patients and randomly divided them into two groups according to a random number table: the experimental group (n = 25) and the control group (n = 25). The control group was treated with conventional nursing measures.

View Article and Find Full Text PDF

Objective: Early education and care (ECEC) is part of the everyday life of most children in developed economies presenting exceptional opportunity to support nutrition and ongoing food preferences. Yet, the degree to which such opportunity is captured in policy-driven assessment and quality ratings of ECEC services is unknown.

Design: Abductive thematic analysis was conducted, guided by key domains of knowledge in nutrition literature and examining identified themes within these domains.

View Article and Find Full Text PDF

There is a complex interplay between the gut microbes, liver, and central nervous system, a gut-liver-brain axis, where the brain impacts intestinal and hepatic function while the gut and liver can impact cognition and mental status. Dysregulation of this axis can be seen in numerous diseases. Hepatic encephalopathy, a consequence of cirrhosis, is perhaps the best studied perturbation of this system.

View Article and Find Full Text PDF

The WOUND-Q is a patient-reported outcome measure for individuals with any type of chronic wound. This study aimed to identify patient and wound factors associated with the four WOUND-Q health-related quality of life (HRQL) scales: Life impact, Psychological, Sleep, and Social. Adults with a chronic wound were recruited internationally through clinical settings between August 2018 and May 2020, and through an online platform (i.

View Article and Find Full Text PDF

Patients with cancer expect prolonged life (overall survival, OS) or better life (quality of life, QOL) from cancer treatments. However, majority of new cancer drugs are now being approved not based on improved OS or QOL, but based on surrogate endpoints such as tumor shrinkage or delayed tumor progression. These surrogate endpoints, including their validity as a proxy for overall survival, differ based on disease settings and lines of treatment but in general, most surrogate measures have weak correlation with outcomes that matter to patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!